Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04NLG
|
|||
| Former ID |
DNC000348
|
|||
| Drug Name |
BRL 43694A
|
|||
| Synonyms |
Granisetron HCl; Granisetron hydrochloride; 107007-99-8; Kytril; Granisetron (Hydrochloride); Kytril Injection; BRL 43694A; 1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide hydrochloride; 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide hydrochloride; 1044956-47-9; BRL-43694A; Granisetron hydrochloride [USAN]; endo-1-Methyl-N-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide hydrochloride
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H25ClN4O
|
|||
| Canonical SMILES |
CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C.Cl
|
|||
| InChI |
1S/C18H24N4O.ClH/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17;/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23);1H
|
|||
| InChIKey |
QYZRTBKYBJRGJB-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 107007-99-8
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
515009, 8189592, 15274123, 43122086, 49982468, 57315405, 78083177, 81043816, 85174193, 92713591, 93302139, 99437248, 104333316, 117450531, 118842170, 124757181, 125163985, 125337366, 125536405, 126584197, 126624678, 126655951, 126667005, 134339794, 135692113, 136949093, 137102174, 144076169, 152034350, 162037555, 162176438, 163329493, 163565127, 164196548, 166233721, 175610936, 196111874, 210279181, 210281504, 223389586, 223654098, 224361347, 226420070, 251886408, 251971070, 252156863
|
|||
| ADReCS Drug ID | BADD_D01041 | |||
| SuperDrug ATC ID |
A04AA02
|
|||
| SuperDrug CAS ID |
cas=109889090
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | 5-HT 3 receptor (5HT3R) | Target Info | Antagonist | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | BRL 43694A--a 5-hydroxytryptamine receptor blocker as an antiemetic in cytostatic therapy. Schweiz Med Wochenschr. 1989 Jun 10;119(23):831-4. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.